EuroPCR 2018

EuroPCR 2018
The World-Leading Course in Interventional
Cardiovascular Medicine

    EuroPCR - Philips - Booth F18 on level 1

    22-25 May 2018 - Palais des Congrès, Paris

       

    No silos. No limits.

    When it comes to health, people deserve the best. Yet despite advances, progress is too often slowed. By systems that can’t communicate. By data that gets locked in silos. By clinicians who can’t see the full picture fast enough and patients who feel lost in the system. 

     

    At Philips, we collaborate on designing innovations to seamlessly bring together people, data and technology for personalized, actionable insights. This results in bringing cardiovascular care professionals and their patients together through the integration of data and targeted information across the care continuum. 

     

    We aim to deliver seamless cardiovascular care and improved workflows to reduce variation in the standard of care, and to find the optimal pathways for better clinical outcomes, lower costs, and increased patient and staff satisfaction – that’s health with no bounds.

    Guiding tomorrow's innovation
    Watch the video and see how Philips is removing the bounds of care

    Please complete the form below to receive the EuroPCR symposia recording

    Contact information

    * This field is mandatory
    *

    Contact details

    *
    *
    *

    Company details

    *
    *

    How do you want to explore Philips Azurion?

     

    At EuroPCR you will be able to visit the Philips Azurion Experience at our booth F18 on level 1.

     

    Azurion Experience Imac

    Please complete the form below to receive the EuroPCR symposia recording

    Contact information

    * This field is mandatory
    *

    Contact details

    *
    *
    *

    Company details

    *
    *

    Proven outcomes.1,2 Superior value.1,3

     

    Health economic data from the DEFINE FLAIR trial demonstrates an iFR-guided strategy offers reduced costs and improved care compared to an FFR-guided strategy.

    Proven outcomes

     
    • Validated in more than 4,500 patients1,2
    • Consistent outcomes as with FFR
    • 0.89 cut-point backed by data1,2,4
    Graphics

    Superior value

     
    • 10% Cost saving per patient
    • 10% reduction in procedure time
    • 90% reduction in patient discomfort1
    Graphic cluster

    1. Davies JE, et al., DEFINE-FLAIR: A Multi- Centre, Prospective, International, Randomized, Blinded Comparison of Clinical Outcomes and Cost Efficiencies of iFR and FFR Decision-Making for Physiological Guided Coronary Revascularization. New England Journal of Medicine, epub March 18, 2017 

    2. Gotberg M, et al., Instantaneous Wave-Free Ratio Versus Fractional Flow Reserve Guided Intervention (IFR-SWEDEHEART): A Multicenter, Prospective, Registry-Based Randomized Clinical Trial. New England Journal of Medicine, epub March 18, 2017

    3. Patel M. “Cost-effectiveness of instantaneous wave-Free Ratio (iFR) compared with Fractional Flow Reserve (FFR) to guide coronary revascularization decision-making.” Late-breaking Clinical Trial presentation at ACC on March 10, 2018.  

    4. An iFR cut-point of 0.89 matches best with an FFR ischemic cut-point of 0.80 with a specificity of 87.8% and sensitivity of 73.0%. (From ADVISE II, and iFR Operator’s Manual 505-0101.23)

    Learn from each other! Bring your cases and share your tips & tricks with your peers and experts.

     

    In the Cath Lab, clinical expertise, rapid response and team work all play a critical role in determining patient outcomes. We invite you to come together as a clinical community, review challenging or unusual cases, share your knowledge and techniques, and discuss informally the best ways to managed complications with experts.

     

    If you have a complicated or interested case which offers teaching points for enhancing quality care, please register your case to present it and discuss it with peers and experts at our booth during EuroPCR!

     

    Your case may be selected for one of the following sessions:

    • Coronary complex cases
    • Cases based discussion on TAVR and TMVR
    IntelliSpace Cardiovascular empowers our care teams with integrated, comprehensive data within one system that arms them with the relevant actionable data.
    Guiding tomorrow's innovation

    What's trending

    Press inquiries:

     

    For EuroPCR, Press Inquiries, please contact

     

    Fabienne van der Feer

    fabienne.van.der.feer@philips.com

    Twitter: @FC_Feer  

     

    News

    @PhilipsLiveFrom

    Read more